Advertisement

Cytokine-induced Inhibition of Myc Activity in Monocytic Cells

  • L.-G. Larsson
  • F. Bahram
  • S. Wu
  • F. Öberg
  • K. Nilsson
  • B. Lüscher
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 224)

Abstract

The c-myc proto-oncogene plays an important role in the regulation of cell proliferation, differentiation and apoptosis. It encodes a transcription factor of the basic region/helix-loop-helix/leucine zipper (bHLHZip) family and binds specifically to certain E-box DNA elements and activates transcription from promoters containing such elements by forming heterodimers with the bHLHZip protein Max (Blackwood et al. 1991, Prendergast et al. 1991, for review see Henriksson and Lüscher 1996). Max on the other hand was recently shown to form heterodimers with a number of other bHLHZip proteins; Mad1, Mxi1, Mad3 and Mad4, referred to as the Mad family (Ayer et al. 1993, Zervos et al. 1993, Hurlin et al. 1995a). These are, like c-Myc, dependent on Max for their activity and bind the same DNA elements as Myc:Max heterodimers. The Mad proteins seem to act as negative regulators of growth and inhibit the transactivating and transforming capacity of Myc (for review see Henriksson & Lüscher 1996). This repressive activity depends on the N-terminus of Mad which is required for interaction with mammalian homologues of the yeast repressor protein Sin3 (Ayer et al. 1995, Schreiber-Agus et al. 1995).

Keywords

Nonreceptor Protein Tyrosine Kinase CACGTG Sequence Mad1 mRNA Mad1 Protein Expression Monocytic Differentiation Marker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ayer DE, Eisenman RN (1993) A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev 7:2110–2119.PubMedCrossRefGoogle Scholar
  2. Ayer DE, Kretzner L, Eisenman RN (1993) Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211–222.PubMedCrossRefGoogle Scholar
  3. Ayer DE, Lawrence QA, Eisenman RN (1995) Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767–776.PubMedCrossRefGoogle Scholar
  4. Blackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211–1217.PubMedCrossRefGoogle Scholar
  5. Blackwood E.M, Lüscher B, Eisenman RN (1992) Myc and Max associate in vivo. Genes & Dev. 6:71–80.CrossRefGoogle Scholar
  6. Henriksson M, Luscher B (1996) Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 68:109–182.PubMedCrossRefGoogle Scholar
  7. Hurlin PJ, Queva C, Koskinen PJ, Steingrimsson E, Ayer DE, Copeland NG, Jenkins NA, Eisenman RN (1995a) Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 14:5646–5659.PubMedCentralPubMedGoogle Scholar
  8. Hurlin PJ, Foley KP, Ayer DE, Eisenman RN, Hanahan D, Arbeit JM (1995b) Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11:2487–2501.PubMedGoogle Scholar
  9. Klefstrom J, Vastrik I, Saksela E, Valle J, Eilers M, Alitalo K (1994) c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha. EMBO J 13:5442–5450.PubMedCentralPubMedGoogle Scholar
  10. Larsson LG, Ivhed I, Gidlund M, Pettersson U, Vennstrom B, Nilsson K (1988) Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene. Proc Natl Acad Sci U S A 85:2638–2642.PubMedCentralPubMedCrossRefGoogle Scholar
  11. Larsson LG, Oberg F, Stockbauer P, Masucci MG, Nilsson K (1992) Suppression of basal, PMA- and IFN-alpha-, but not IFN-gamma-induced expression of HLA class I in v-myc- transformed U-937 monoblasts. Int J Cancer 52:759–765.PubMedCrossRefGoogle Scholar
  12. Larsson LG, Pettersson M, Oberg F, Nilsson K, Luscher B (1994) Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene 9:1247–1252.PubMedGoogle Scholar
  13. Luscher B, Eisenman RN (1988) c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol Cell Biol 8:2504–2512.PubMedCentralPubMedGoogle Scholar
  14. Massague’, J (1996) TGFß signalling: receptors, transducers and Mad proteins. Cell 85:947–950.CrossRefGoogle Scholar
  15. Oberg F, Larsson LG, Anton R, Nilsson K (1991) Interferon gamma abrogates the differentiation block in v-myc-expressing U-937 monoblasts. Proc Natl Acad Sci USA 88:5567–5571.PubMedCentralPubMedCrossRefGoogle Scholar
  16. Prendergast GC, Lawe D, Ziff EB (1991) Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65:395–407.PubMedCrossRefGoogle Scholar
  17. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI, DePinho RA (1995) An amino-terminal domain of Mxil mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80:777–786.PubMedCrossRefGoogle Scholar
  18. Taniguchi T (1995) Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251–255.PubMedCrossRefGoogle Scholar
  19. Vastrik I, Kaipainen A, Penttila TL, Lymboussakis A, Alitalo R, Parvinen M, Alitalo K (1995) Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J Cell Biol 128:1197–1208.PubMedCrossRefGoogle Scholar
  20. Zervos AS, Gyuris J, Brent R (1993) Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223–232.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • L.-G. Larsson
    • 1
    • 2
  • F. Bahram
    • 1
  • S. Wu
    • 1
  • F. Öberg
    • 1
  • K. Nilsson
    • 1
  • B. Lüscher
    • 2
  1. 1.Laboratory of Tumor Biology, Department of PathologyUniversity of UppsalaUppsalaSweden
  2. 2.Institut für MolekularbiologieMedizinische Hochschule HannoverHannoverGermany

Personalised recommendations